Molecular Therapy Halts Progression of Degenerative Disc Disease
The tremendous cost, pain and disability associated with degenerative disc disease (DDD) makes the development of a biological agent that can mitigate the course of DDD a critical unmet need …

Add Comment

Your email address will not be published. Required fields are marked *

Registered Charity #118853613RR0001

(416) 585-7902, ext.238

Unit 6, 186 Spadina Ave.
Toronto, ON M5T 3B2